• +598 29008192
  • info@servinfo.com.uy

Crispr'd Cells Show Promise in First US Human Safety Trial

Crispr'd Cells Show Promise in First US Human Safety Trial

Using genetically-edited cells to supercharge the immune system caused no adverse effects in cancer patients. It’s too soon to tell if it can be a cure.
Source: Wired

Belen De Leon